l 2011
WO
441. VITRONECTIN:KERATINOCYTE GROWTH FACTOR CHIMERAS
Abstract
Isolated protein complexes are provided comprising keratinocyte growth factor and vitronectin, or at least domains thereof that enable binding to and activation of both a...
Isolated protein complexes are provided comprising keratinocyte growth factor and vitronectin, or at least domains thereof that enable binding to and activation of both a...
The invention discloses a tissue engineering lymph node model and a construction method thereof and belongs to the technical field of tissue engineering and regenerative...
The invention relates to a cell injection for treating bone injury and a preparation method thereof, belonging to the field of tissue engineering. The injection...
This invention provides a composition for controlled-release of polypeptide growth factors useful in tissue repair or engineering. The composition include a polypeptide growth factor covalently...
This application provides a microsphere suitable for tissue engineering that comprises connective tissue growth factor (CTGF). Also provided is a matrix, material or scaffold suitable...
The invention belongs to the technical fields of tissue engineering and biological materials, in particular to a transplanting material of fat granule tissues compounded with...
The invention relates to a scaffold material for tissue engineering construction and a preparation method thereof, and particularly relates to a compound tissue engineering scaffold...
The invention provides tissue engineering skin with a sebaceous gland-like structure. In the tissue engineering skin, a dermis layer is formed by distributing placenta mesenchymal...
The present invention relates to orthopaedic implants having a fenestrated hollow shell (39) and a biologic core. These design features provide an improved interface between...
The present invention discloses a producing method for tissue engineering cornea. The method involves using amniotic epithelial cells and amniotic stromal cells as seed cells,...
PROBLEM TO BE SOLVED: To provide isolated protein complexes including a growth factor, e.g. insulin-like growth factor (IGF)-I, IGF-II, vascular endothelium growth factor (VEGF) or...
The invention discloses a natural polymer-hydroxyapatite bone tissue engineering scaffold material with a secondary three-dimensional network structure and a preparation method thereof. The method comprises...
Isolated protein complexes are provided comprising growth factors such as IGF-I, IGF-II, EGF, bFGF, or KGF and fibronectin, or at least domains thereof that enable...
The invention discloses a core-shell microcapsule and a preparation method thereof. The core-shell microcapsule comprises a core layer and a shell layer, wherein the core...
The present disclosure relates to controlling the release of growth factors for the promotion of angiogenesis. The growth factors or a polymer matrix are modified...
The present disclosure relates to controlling the release of growth factors for the promotion of angiogenesis. The growth factors or a polymer matrix are modified...
The invention relates to a vascular endothelial growth factor-165 (VEGF-165) and HbetaD3 double gene plasmid vector and a constructing method thereof. By using a pVIVO1-mcs...
The invention discloses a method for preparing micro-grade polymer gel microspheres capable of loading protein. In the invention, with polyethyleneglycol diacrylate as monomers, the micro-class...
The invention discloses a cord blood mesenchyme stem cell as well as a preparation method and application thereof. The CD105 positive (CD105+) cord blood mesenchyme...
PURPOSE: A fusion protein for promoting bone regeneration is provided to specifically target hydroxyapatite and to enhance differentiation and proliferation of osteoblast. CONSTITUTION: A fusion...